Australia’s white label identity crisis: a story of quality, branding and margins

White label brands are continuing to pop up in Australia, further cluttering the market. But, argues SOMAÍ Pharmaceuticals chairman and interim CEO Michael Sassano, their days are likely to be numbered as margins are squeezed and patients become better informed

As the medical cannabis industry in Australia continues to boom with more patients than ever, and the most modern products available on the global cannabis market, white-labeled brands are popping up overnight in droves.